aminoimidazole carboxamide has been researched along with carbon monoxide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KC; Kim, HJ; Kim, YM; Lee, JH; Nizamutdinova, IT; Seo, HG | 1 |
1 other study(ies) available for aminoimidazole carboxamide and carbon monoxide
| Article | Year |
|---|---|
Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-gamma activations in endothelial cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Anilides; Anti-Inflammatory Agents; Benzophenones; Carbon Monoxide; Cell Adhesion; Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme Activators; Glucose; Humans; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Organometallic Compounds; PPAR gamma; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Ribonucleotides; Signal Transduction; Thiazolidinediones; Time Factors; Transfection; Troglitazone; Tyrosine | 2009 |